NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Anodic Stimulation in Parkinson's Disease
Anodic Stimulation in Parkinson's Disease
Active Not RecruitingNA
Sponsor: University of South Florida
Conditions: Parkinson Disease (PD)
Interventions: Mixed Cathodic/Anodic, Pure Cathodic, Pure Anodic
Countries: United States
Randomized, double-blind, crossover design, interventional study to assess the differences between mixed cathodic/anodic, pure cathodic, and pure anodic stimulation with respect to efficacy, side effect thresholds, symptom control, and quality of life in Parkinson's Disease patients implanted with Boston Scientific Cartesia directional DBS leads in the bilateral STN.
Eligibility overview
Sex: ALL
Age: 40 Years to 80 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Patients that are between the ages of 40-80 years of age. * Patients diagnosed with Idiopathic Parkinson's Disease that are treated with bilateral STN DBS Boston Scientific Vercise Cartesia directional leads for at least 3 months. * Patients whose DBS settings can be optimized to include anodic and cathodic stimulation. Exclusion Criteria: * Parkinson's Disease patients implanted with DBS leads outside of FDA labeling. * Patients who are not chronically using anodic stimulation parameters.
Locations (1)
- Tampa, Florida, United States